New study tracks pancreatic cancer screening in gene mutation carriers
NCT ID NCT02478892
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This observational study follows 200 people with inherited mutations in BRCA1/2, ATM, or PALB2 genes who are already undergoing regular pancreatic cancer screening with endoscopic ultrasound or MRI. Researchers will track how often these imaging tests find pre-cancerous or cancerous lesions. The goal is to see if routine screening is feasible and how common these lesions are in this high-risk group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could show that regular screening helps catch pancreatic cancer early in people with certain gene mutations, potentially improving survival.
What could go wrong
This is an early observational study, not a treatment trial. It may not prove that screening saves lives, and results may not apply to all high-risk groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Abramson Cancer Center of the University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19004, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact